Rivus Pharmaceuticals stock

Rivus Pharmaceuticals Stock

HealthTech

Looking to sell Rivus Pharmaceuticals stock or options?

Founded: 2019Funding to Date: $167Mhttps://www.rivuspharma.com

Rivus Pharmaceuticals develops controlled metabolic accelerators aimed at enhancing cardio-metabolic health. The company focuses on improving cellular metabolism and addressing the root causes of common metabolic and cardiovascular diseases. They offer patients oral small-molecule therapeutics that target the fundamental metabolic risk factors contributing to cardiovascular mortality and morbidity.

Investors Include:

RA Capital Management, Medicxi, RxCelerate, Bain Capital Life Sciences, BB Biotech, Longitude Capital.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Unlock My Liquidity